[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Lassa Fever (Lassa Hemorrhagic Fever) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 50 pages | ID: LE920AAC6709EN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Lassa Fever (Lassa Hemorrhagic Fever) Drug pipeline report- 2020 is an annual R&D review of Lassa Fever (Lassa Hemorrhagic Fever) pipeline candidates. The report presents the current status of all major Lassa Fever (Lassa Hemorrhagic Fever) therapeutic compounds. Detailed insights into Lassa Fever (Lassa Hemorrhagic Fever) pipeline development, current status, companies, drug profiles and Lassa Fever (Lassa Hemorrhagic Fever) preclinical and clinical trials are included.

2020 Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Market Insights
Lassa Fever (Lassa Hemorrhagic Fever) disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Lassa Fever (Lassa Hemorrhagic Fever) therapies, pipeline by phase and others are included.

Lassa Fever (Lassa Hemorrhagic Fever) pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Lassa Fever (Lassa Hemorrhagic Fever) Therapeutic Drug candidates
Both active and inactive Lassa Fever (Lassa Hemorrhagic Fever) pipeline drug candidates are included in the report

Lassa Fever (Lassa Hemorrhagic Fever) Clinical Trials and preclinical Studies
Lassa Fever (Lassa Hemorrhagic Fever) In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Lassa Fever (Lassa Hemorrhagic Fever) pipeline market developments
Lassa Fever (Lassa Hemorrhagic Fever) Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Lassa Fever (Lassa Hemorrhagic Fever) pipeline companies in active development
The report analyzes Lassa Fever (Lassa Hemorrhagic Fever) pipeline of the below companies-

Celgene Corp, Etubics Corporation, Fabentech, GeoVax Labs Inc, Inovio Pharmaceuticals Inc, Intervir Therapeutics, Janssen Vaccines, Kineta Inc, Medigen Inc, Profectus Biosciences, RetroVirox Inc, Themis Bioscience, Toyama Chemical Co Ltd, Zalgen Labs, CureVac

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
15 Companies investing in Lassa Fever (Lassa Hemorrhagic Fever) pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Lassa Fever (Lassa Hemorrhagic Fever) pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. LASSA FEVER (LASSA HEMORRHAGIC FEVER) PIPELINE MARKET INSIGHTS, 2020

1.1 Lassa Fever (Lassa Hemorrhagic Fever) Disease Overview
1.2 Lassa Fever (Lassa Hemorrhagic Fever) Drug Pipeline Snapshot, 2020
  1.2.1 Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs by Phase
  1.2.2 Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs by Company
  1.2.3 Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs by Mechanism of Action
  1.2.4 Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs by Route of Administration

2. LASSA FEVER (LASSA HEMORRHAGIC FEVER) COMPANY WISE PIPELINE DETAILS

Celgene Corp Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Etubics Corporation Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Fabentech Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
GeoVax Labs Inc Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Inovio Pharmaceuticals Inc Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Intervir Therapeutics Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Janssen Vaccines Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Kineta Inc Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Medigen Inc Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Profectus Biosciences Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
RetroVirox Inc Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Themis Bioscience Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Toyama Chemical Co Ltd Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Zalgen Labs Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
CureVac Lassa Fever (Lassa Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. LASSA FEVER (LASSA HEMORRHAGIC FEVER) DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. LASSA FEVER (LASSA HEMORRHAGIC FEVER) PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications